Page 21 - ஜப்பான் அமைச்சகம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
美모더나, 일본에 백신생산 검토 …한국은?
edaily.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from edaily.co.kr Daily Mail and Mail on Sunday newspapers.
모더나, 일본 내 백신 생산 검토…CEO 업계와 협의 중
yna.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yna.co.kr Daily Mail and Mail on Sunday newspapers.
일본 코로나 신규확진 5천명대…AZ백신 승인하되 접종은 보류
yna.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yna.co.kr Daily Mail and Mail on Sunday newspapers.
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
ACCESSWIRE
19 May 2021, 20:05 GMT+10
Clinical Research Organization, Accerise Inc., Has Been Retained To Work With RepliCel and Its Other Service Providers To Prepare Study Documentation, Plans, and Approvals for Clinical Evaluation by Multiple Clinical Sites in Japan
VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has retained leading clinical research organization, Accerise Inc, with offices in Tokyo and Osaka, to lead the planning and preparations for clinical research studies of RepliCel s skin rejuvenation (RCS-01) and tendon regeneration (RCT-01) cell therapy products in Japan.
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.